The thyroid is an endocrine gland that makes hormones to regulate many activities in the body, including metabolism. Diseases of the thyroid can cause the gland to release too many hormones — as in the case of hyperthyroidism — or too few.

According to the American Thyroid Association, at least 1 in 8 people (in the US) will develop a thyroid condition during their lifetime, and women are up to 8 times more likely than men to have a thyroid condition.1 As many as 60% of people living with thyroid disease are undiagnosed.1

Women are up to 8 times more likely than men to develop a thyroid condition1

In hyperthyroidism, radioactive iodine is commonly used to help control overactive thyroid tissues and cells with or without anti-thyroid medication. After surgery, radioactive iodine can be used to destroy remaining thyroid tissue or localized cancer cells and metastases

Sustaining the Vital Role of Nuclear Medicine in the Diagnosis and Treatment of Thyroid Disease

Jubilant Radiopharma maintains an unwavering commitment to provide consistent access to pharmaceutical-grade radioactive iodine (I-131) that is manufactured in accordance to strict quality standards.

Learn more about thyroid cancer.

Learn more about hyperthyroidism.


1. American Thyroid Association. General Information/Press Room. Revised 2014. Available here. Accessed on June 11, 2020.


This information is not intended as medical advice. Responsibility for patient care resides with the healthcare professional on the basis of his or her professional license, experience and knowledge of the patient. For full Prescribing Information including indications, contraindications, warnings, precautions and adverse events, please see the appropriate product labeling.

Clinical Resources

Jubilant Radiopharma has made the resources below available for health care professionals who diagnose and treat differentiated thyroid cancer and hyperthyroidism patients:

We use cookies to recognize your repeat visits and preferences, as well as to measure the effectiveness
of campaigns and analyze traffic. If you continue to use this site we will assume your acceptance.